MCHRI Drug & Device Development Training Program


DEADLINE: October 1, 2023


Application materials must be submitted by Sunday, October 1, 2023 at 5:00 PM PT.


Clinical Fellows (MD or MD, PhD)*, Instructors, and Faculty who are able to complete the 4-week experience in four 1- week blocks, two 2-week blocks, or one 4-week block within a 4 month timeframe from a projected start date of November 1, 2023

*The Stanford School of Medicine, Department of Graduate Medical Education (GME) Committee has approved the D3 Training Program as an elective to fulfill a portion of the fellow’s training.


To apply for the program, please submit the following as a compiled PDF document via email by Sunday, October 1, 2023 to Jessica Li (

  • 1-page personal statement
  •  Applicant’s NIH Biosketch or CV
  • Letter of Nomination** from Department Chair, Division Chief or Training Program Director 
    • **Letter must include commitment of salary support during the internship period


Each training engagement may have specific costs associated to the format (virtual, hybrid, in-person). The program has funding available for travel and other expenditures. Each training scenario will be evaluated once the awarded applicant and industry site location are matched. Any awarded funds will be provided via formal Notice of Award with the awardee’s financial representative responsible for reconciliation of proposed expenditures to award budget.

Forms for Applicants

"D3 was a terrific program that fills a gap in fellowship education and provides a bridge to industry. Through the program, I joined a local biosciences company to work on developing a new therapeutic and diagnostic product. It was extremely valuable to be able to participate in these projects, especially as I gained experience moving through Phase 1 and Phase 2 trials."

Lauren Kushner, MD
Pediatric Infectious Diseases Fellow
Lucile Packard Children’s Hospital Stanford

For questions about applying, please contact Jessica Li.